These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26583494)

  • 21. An atypical course of myasthenia gravis.
    Labana SS; Qureshi S; Nandakumar T; Cervellione KL; Venkatraman GK; Thakore H; Gintautas J
    Proc West Pharmacol Soc; 2007; 50():140-2. PubMed ID: 18605252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapsyn congenital myasthenic syndrome worsened by fluoxetine.
    Visser AC; Laughlin RS; Litchy WJ; Benarroch EE; Milone M
    Muscle Nerve; 2017 Jan; 55(1):131-135. PubMed ID: 27397848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myasthenia gravis in two cats.
    Indrieri RJ; Creighton SR; Lambert EH; Lennon VA
    J Am Vet Med Assoc; 1983 Jan; 182(1):57-60. PubMed ID: 6822462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phenotypic Differences in 2 Unrelated Cases Carrying Identical DOK7 Mutations.
    Bissay V; Maselli RA
    J Clin Neuromuscul Dis; 2019 Sep; 21(1):30-34. PubMed ID: 31453852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoimmune myasthenia gravis in a ferret.
    Couturier J; Huynh M; Boussarie D; Cauzinille L; Shelton GD
    J Am Vet Med Assoc; 2009 Dec; 235(12):1462-6. PubMed ID: 20001782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Congenital myasthenic syndrome due to rapsyn deficiency: A case report with a new mutation and compound heterozygosity.
    Espinoza IO; Reynoso C; Chávez G; Engel AG
    Medwave; 2019 Jun; 19(5):e7645. PubMed ID: 31226102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronary vasospasm secondary to hypercholinergic crisis: an iatrogenic cause of acute myocardial infarction in myasthenia gravis.
    Comerci G; Buffon A; Biondi-Zoccai GG; Ramazzotti V; Romagnoli E; Savino M; Rebuzzi AG; Biasucci LM; Loperfido F; Crea F
    Int J Cardiol; 2005 Sep; 103(3):335-7. PubMed ID: 16098399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DOK7 congenital myasthenic syndrome.
    Palace J
    Ann N Y Acad Sci; 2012 Dec; 1275():49-53. PubMed ID: 23278577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myasthenic Crisis as the First Presentation of Myasthenia Gravis: A Case Report.
    Payus AO; Leow Wen Hsiang J; Leong JQ; Ibrahim A; Raymond AA
    Am J Case Rep; 2021 Jan; 22():e928419. PubMed ID: 33468985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Congenital myasthenic syndrome in the dog breed Gammel Dansk Hønsehund: clinical, electrophysiological, pharmacological and immunological comparison with acquired myasthenia gravis.
    Flagstad A; Trojaborg W; Gammeltoft S
    Acta Vet Scand; 1989; 30(1):89-102. PubMed ID: 2782236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Overview: MuSK/Dok-7].
    Motomura M; Fukuda T; Yoshimura T; Tsujihata M
    Nihon Rinsho; 2008 Jun; 66(6):1140-8. PubMed ID: 18540360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of Lambert-Eaton myasthenic syndrome with possible myasthenia gravis.
    Iqbal M; Connolly S; Langan Y; Redmond J
    Ir Med J; 2012 Jun; 105(6):183-4. PubMed ID: 22973658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel truncating RAPSN mutations causing congenital myasthenic syndrome responsive to 3,4-diaminopyridine.
    Banwell BL; Ohno K; Sieb JP; Engel AG
    Neuromuscul Disord; 2004 Mar; 14(3):202-7. PubMed ID: 15036330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DOK7 mutations presenting as a proximal myopathy in French Canadians.
    Srour M; Bolduc V; Guergueltcheva V; Lochmüller H; Gendron D; Shevell MI; Poulin C; Mathieu J; Bouchard JP; Brais B
    Neuromuscul Disord; 2010 Jul; 20(7):453-7. PubMed ID: 20610155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel compound heterozygous GFPT1 mutations in a family with limb-girdle myasthenia with tubular aggregates.
    Luo HY; Zhao L; Mao CY; Yang ZH; Yang J; Wang YL; Niu HX; Liu YT; Shi CH; Xu YM
    Neuromuscul Disord; 2019 Jul; 29(7):549-553. PubMed ID: 31255525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overview of myasthenia gravis.
    Arora Y; Li Y
    Hosp Pract (1995); 2013; 41(4):40-50. PubMed ID: 24145588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of myasthenia gravis.
    Schwendimann RN; Burton E; Minagar A
    Am J Ther; 2005; 12(3):262-8. PubMed ID: 15891271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repetitive stimulation in myasthenia gravis: decrementing response revealed by anticholinesterase drugs.
    Scoppetta C; Casali C; D'Agostini S; La Cesa I; Parisi L
    Electroencephalogr Clin Neurophysiol; 1990 Feb; 75(2):122-4. PubMed ID: 1688768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is exercise necessary with repetitive nerve stimulation in evaluating patients with suspected myasthenia gravis?
    Rubin DI; Hentschel K
    Muscle Nerve; 2007 Jan; 35(1):103-6. PubMed ID: 17024676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variable phenotypes associated with mutations in DOK7.
    Anderson JA; Ng JJ; Bowe C; McDonald C; Richman DP; Wollmann RL; Maselli RA
    Muscle Nerve; 2008 Apr; 37(4):448-56. PubMed ID: 18161030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.